Gabapentin Dosing for Neuropathic Pain
Start gabapentin at 300 mg on day 1, increase to 600 mg/day (300 mg twice daily) on day 2, then 900 mg/day (300 mg three times daily) on day 3, and titrate upward by 300 mg every 3–7 days to reach the target therapeutic dose of 1800–3600 mg/day in three divided doses. 1, 2
Initial Dosing and Titration Schedule
Begin with 300 mg as a single dose on day 1, then 300 mg twice daily on day 2, then 300 mg three times daily (900 mg/day total) on day 3. 1, 2
After reaching 900 mg/day on day 3, increase by 300 mg increments every 3–7 days as tolerated until you reach the minimum effective dose of 1800 mg/day (600 mg three times daily). 1, 2
The target therapeutic range is 1800–3600 mg/day in three divided doses, with the maximum dose being 3600 mg/day (1200 mg three times daily). 1, 2, 3
Three-times-daily dosing is mandatory because gabapentin has nonlinear, saturable absorption pharmacokinetics; the maximum interval between doses must not exceed 12 hours. 1, 2
Target Dose and Expected Efficacy
The minimum effective dose for most neuropathic pain conditions is 1800 mg/day (600 mg three times daily), with moderate-quality evidence supporting efficacy at 1800–3600 mg/day. 1, 4
At therapeutic doses of 1800–3600 mg/day, approximately 32–38% of patients achieve at least 50% pain reduction compared to 17–21% with placebo (NNT 5.9–6.7), based on trials in postherpetic neuralgia and painful diabetic neuropathy. 1, 4
Allow 3–8 weeks for titration plus an additional 2 weeks at the maximum tolerated dose before declaring treatment failure; an adequate trial may require 2 months or more because efficacy develops gradually over several weeks. 1, 5
Dosing in Older Adults
In elderly patients, start at the lower end of the dosing range (100–200 mg/day) and use slower titration with increases every 3–7 days or longer to minimize adverse effects. 1, 5
Elderly patients experience higher rates of adverse effects: dizziness (
19%), somnolence (14%), peripheral edema (7%), and gait disturbance (9%), which increase fall risk. 1, 5The effective dose in older adults may be lower than the standard adult range, and slower titration is essential to reduce dizziness-related falls. 1, 5
Renal Impairment Dose Adjustments
Mandatory dose reduction is required based on creatinine clearance (CLcr) because gabapentin is eliminated primarily by renal excretion; calculate CLcr using the Cockcroft-Gault equation before initiating therapy. 1, 2
| Creatinine Clearance (mL/min) | Total Daily Dose (mg/day) | Dosing Frequency |
|---|---|---|
| ≥60 | 900–3600 | Three times daily |
| 30–59 | 400–1400 | Twice daily |
| 15–29 | 200–700 | Once daily |
| <15 | 100–300 | Once daily |
- For patients on hemodialysis, administer maintenance doses based on CLcr plus a supplemental post-hemodialysis dose (125–350 mg) after each 4-hour dialysis session. 2
Common Adverse Effects and Management
The most common adverse effects are dizziness (19%), somnolence (14%), peripheral edema (7%), and gait disturbance (9%), which are typically mild to moderate, dose-dependent, and often transient, usually subsiding within approximately 10 days. 1, 3, 6
Adverse event withdrawals occur in 11% of patients versus 8.2% with placebo (NNH 30), but serious adverse events are no more common with gabapentin (3.2%) than placebo (2.8%). 4
Start with lower doses and implement gradual titration to minimize peak-related side effects such as dizziness and sedation. 1
Critical Pitfalls to Avoid
Never use once-daily or twice-daily dosing for standard gabapentin; three-times-daily administration is essential due to saturable absorption. 1
Do not rush titration in elderly patients, as this dramatically increases fall risk from dizziness; use slower increments every 3–7 days or longer. 1, 5
Do not discontinue abruptly; taper gradually over at least 1 week to avoid withdrawal symptoms. 1
Do not declare treatment failure before completing the full 2-month trial at therapeutic doses (including titration time plus 2 weeks at maximum tolerated dose), as efficacy develops gradually over several weeks. 1, 5
Always assess renal function before initiating therapy and adjust doses accordingly; this is non-negotiable, especially in elderly patients who invariably have reduced renal function. 1, 5, 2
Combination Therapy Options
Gabapentin may be used as a co-analgesic in combination with opioids, tricyclic antidepressants (e.g., nortriptyline), or topical agents for optimal pain management. 1
Adding nortriptyline to gabapentin provides superior pain relief compared with either agent alone in randomized controlled trials. 1
Co-administration of low-dose gabapentin with an opioid allows better analgesia while permitting lower opioid dosing. 1